Erasca
ERAS
ERAS
109 hedge funds and large institutions have $140M invested in Erasca in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
-3
Holders Change %
-2.68%
% of All Funds
1.74%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
48
Reduced
29
Closed
12
Calls
$3K
Puts
$1K
Net Calls
+$2K
Net Calls Change
+$3K
Top Buyers
| 1 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
$3.79M |
| 2 |
AC
Armistice Capital
New York
|
$16.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$3.47M |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
$817K |
| 5 |
HF
HRT Financial
New York
|
$295K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$10.1M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
$521K |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
$7.74M |
| 4 |
Millennium Management
New York
|
$820K |
| 5 |
Renaissance Technologies
New York
|
$1.46M |
